secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lucid Diagnostics Inc. (LUCD)
CIK:        0001799011
Form:       8-K
Filed at:   2023-03-24T23:59:59+00:00
Accession:  0001493152-23-008932
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.03, 3.02, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lucid Diagnostics consummates $11.1M senior secured convertible note with accredited investor
--------------------------------------------------------------------------------

- Closed sale of up to $11,111,110 Senior Secured Convertible Note to an accredited investor as of March 21, 2023.
- Entered into Registration Rights Agreement to register resale of shares underlying the Note; filing deadline 45 days post-closing.
- Parent company PAVmed Inc. (holds ~72% of common stock) agreed via Voting Agreement to vote shares in favor of stockholder resolutions.
- Note convertible into common stock; proceeds from private placement provide additional capital to Lucid Diagnostics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799011/000149315223008932/0001493152-23-008932-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799011/000149315223008932/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-008932

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer